Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dogs may be used to detect breast cancer
Medical detection dog
Medical Detection Dogs has established a reputation in training dogs to 'sniff-out' prostate, renal and bladder cancer using urine samples.

Ground-breaking trial will establish if dogs can detect breast cancer from breath samples.

Medical Detection Dogs has been granted permission to begin the world's first ever breast cancer detection trial using the incredible power of a dogs sense of smell.  

Founded in 2007, the Buckinghamshire charity has established a reputation in training dogs to detect prostate, renal and bladder cancer using urine samples.  It is seen to be the world-leader in its field and advises other smaller clinics in Europe, Australia and the US.

Although it has not yet been determined what it is the dogs detect, it is thought that volatile substances emitted by cancerous cells are present in the urine of cancer patients and give off an odour which is perceptible to dogs.

Dr Claire Guest, founder and CEO of Medical Detection Dogs, who will be principle investigator of the trial, hopes to find volatiles also present in breath samples collected from breast cancer patients.

Dr Guest commented: “This is such a fascinating area to study. It doesn’t seem necessarily logical that breast cancer should lead to volatile substances to be present in breath samples, but we have seen sufficient anecdotal and minor trial evidence to feel confident this is an avenue well worth pursuing.

"If it works, it will revolutionise the way we think about breast cancer."

The charity hopes that they will eventually be able to assist scientists to develop e-noses - electronic systems that are able to detect the odour of cancer through simple, low-cost and non-invasive tests.

Dr Guest said: "If we can prove the principle that breast cancer is detectable of a person's breath, machines could eventually detect that odour."

Previous trials carried out by Medical Detection Dogs include a 2004 study into the detection of bladder cancer using urine samples. The charity has also been working with renal and prostate samples - with prostate cancer achieving a 93 per cent accuracy when sniffing urine samples, compared to the 73 per cent of traditional PSA testing.

Earlier this year, Medical Detection Dogs were invited to demonstrate their work as St James's Palace to an audience including Prince Charles and the Duchess of Cornwall. The Duchess subsequently became a Patron to the charity, which also has the support of welfare and pensions minister, Iain Duncan Smith and comedian Bill Bailey.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.